对线粒体动氨酸相关蛋白-1作为抗癌癌细胞中新化学敏感化点的新见解
Samar Sami Alkafaas1, Omar K Obeid2, Mustafa Ali Radwan3
1Molecular Cell Biology Unit, Division of Biochemistry, Department of Chemistry, Faculty of Science, Tanta University, 31527, Egypt.
Bioorganic chemistry
|June 27, 2024
概括
由Drp-1调节的线粒体动力学在癌症进展和化学抵抗方面至关重要. 抑制Drp-1显示出增强癌症治疗响应性的前景.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 线粒体在癌细胞生存中起着至关重要的作用,影响新陈代谢,信号传递和ROS产生.
- 维护线粒体动力学 (裂变/融合平衡) 对细胞生物能学和健康的细胞过程至关重要.
- 线粒体动态的调节失调,特别是涉及Drp-1,与癌症的进展,入侵,转移和化学抵抗有关.
研究的目的:
- 审查Drp-1在线粒体动态中的作用及其与癌症进展和化学抵抗的联系.
- 以计算方式评估公开可用的DRP-1抑制剂在癌症治疗中的潜力.
主要方法:
- 文献综述侧重于DRp-1,线粒体动力学和癌症.
- 对Drp-1抑制剂的计算评估.
- 对Drp-1在癌症侵袭,转移和化学抵抗中的作用的分析.
主要成果:
- 在各种癌症中观察到高DRP-1水平,与入侵,转移和化学抵抗相关.
- 像Mdivi-1这样的抑制剂可以增强癌细胞对化疗的敏感性.
- 与Mdivi-1相比,一些新型化合物 (Drp1-IN-1,Dynole 34-2,trimethyloctadecylammonium bromide,Schaftoside) 显示出强大的Drp-1抑制作用.
结论:
- 针对Drp-1-介导的线粒体动力学是癌症管理的一个有希望的策略.
- 需要进一步的研究来开发有效的DRP-1抑制剂,以改善癌症治疗结果.
- 这种方法有可能增强癌症治疗和克服化学抵抗.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:46Electron Transport Chain: Complex I and II
12.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.8K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K